Lenvatinib仑伐替尼，乐伐替尼

Hepatocellular Carcinoma: For the treatment of patients with unresectable hepatocellular carcinoma (HCC);
2. Differentiated thyroid cancer: Single drug is used for patients with radioactive iodine-refractory differentiated thyroid cancer with local recurrence/metastasis or progression;
3. Renal cell carcinoma: used in combination with everolimus to treat patients with advanced renal cell carcinoma who have previously received vascular endothelial growth factor-targeted therapy.